Mandate to record gift payments to doctors delayed; FDA issues rule on reporting med manufacturing interruptions;

@FiercePharma: Covidien plans to spin off pharma division into a separate company to better compete in the pain-management area. News | Follow @FiercePharma

> A requirement for U.S. drugmakers and device companies to record all payments and gifts to doctors above $10 has been delayed until sometime in 2012. Story

> The FDA has issued an interim final rule requiring manufacturers to report interruptions in production of critical drugs. Release

> Spectrum Pharmaceuticals is generating a significant surge in revenue by developing and marketing neglected cancer drugs it acquires from other companies. Story

> UPS ($UPS) is hoping to cash in on the growing pharma logistics market as expiring patents on big meds like Lipitor push up demand for generic exports from Asia. News

> Investors at Swiss orthopedics maker Synthes overwhelmingly voted to back Johnson & Johnson's $21.3 billion offer to buy the company. Story

Biotech News

@FierceBiotech: Interesting model: Spectrum Pharma spinning gold from other companies' failures. Story | Follow @FierceBiotech

@JohnCFierce: BioSante is getting blasted on the failed libido gel study. Blames the dread placebo effect. Article | Follow @JohnCFierce

> Vertex CEO stepping down after banner year. More

> BioSante shares nosedive after libido gel flunks pivotal studies. News

> Ipsen plans new hires, $45M R&D expansion as it relocates U.S. HQ. Item

> Cerulean garners $15M for PhII lung cancer study. Article

> Third Rock provides $34M bankroll for an obesity/diabetes startup. Piece

Vaccine News

> Preclinical vaccine shrinks tumors 80%. Story

> Novartis opens doors to $1B vaccine plant. Article

> GE jumps in to biologics, vaccine manufacturing game. More

> Antigen Express vaccine cuts breast cancer recurrence. News

Pharma Manufacturing News

> Watch for pharma/carmaker collaboration pitfalls. More

> J&J releases Doxil batch; Ben Venue troubles detailed in FDA report. Article

> Novartis, HHS unveil pandemic-ready vax plant. Item

> Study finds substandard drugs cheaper than fakes. News

> Forecast: Pharma wants CMO consulting, regulatory support. Report

And Finally... Are you shy? Well, there could be help. A new study from Concordia University that will be published in the journal Psychopharmacology has found that a form of intranasal oxytocin spray can smooth awkward social encounters. Article

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.